These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16179662)

  • 1. Symptom-oriented versus syndrome approaches to resolving heterogeneity of neuropsychological functioning in schizophrenia.
    Cohen AS; Docherty NM
    J Neuropsychiatry Clin Neurosci; 2005; 17(3):384-90. PubMed ID: 16179662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that specific executive functions predict symptom variance among schizophrenia patients with a predominantly negative symptom profile.
    Donohoe G; Corvin A; Robertson IH
    Cogn Neuropsychiatry; 2006 Jan; 11(1):13-32. PubMed ID: 16537231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of self-report and performance-based measures of everyday functioning in individuals with schizophrenia: implications for measure selection.
    Elliott CS; Fiszdon JM
    Cogn Neuropsychiatry; 2014; 19(6):485-94. PubMed ID: 24901357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of effort, cognitive expectancy appraisals and coping style in the maintenance of the negative symptoms of schizophrenia.
    Avery R; Startup M; Calabria K
    Psychiatry Res; 2009 May; 167(1-2):36-46. PubMed ID: 19339056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differentiation of deficit and non-deficit schizophrenia based on cognitive functions].
    Polgár P
    Ideggyogy Sz; 2011 Mar; 64(3-4):128-32. PubMed ID: 21545010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight, neurocognitive function and symptom clusters in chronic schizophrenia.
    Collins AA; Remington GJ; Coulter K; Birkett K
    Schizophr Res; 1997 Oct; 27(1):37-44. PubMed ID: 9373893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
    Savilla K; Kettler L; Galletly C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychopathologic and cognitive investigations in schizophrenia].
    Farkas M
    Orv Hetil; 2009 Mar; 150(9):423-9. PubMed ID: 19228571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of insight into clinical symptoms versus insight into neuro-cognitive symptoms in schizophrenia.
    Medalia A; Thysen J
    Schizophr Res; 2010 May; 118(1-3):134-9. PubMed ID: 19840898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of neurocognitive deficits and symptoms on disability in schizophrenia.
    Ertuğrul A; Uluğ B
    Acta Psychiatr Scand; 2002 Mar; 105(3):196-201. PubMed ID: 11939973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology.
    Bak N; Ebdrup BH; Oranje B; Fagerlund B; Jensen MH; Düring SW; Nielsen MØ; Glenthøj BY; Hansen LK
    Transl Psychiatry; 2017 Apr; 7(4):e1087. PubMed ID: 28398342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up.
    Milev P; Ho BC; Arndt S; Andreasen NC
    Am J Psychiatry; 2005 Mar; 162(3):495-506. PubMed ID: 15741466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter?
    Varga M; Magnusson A; Flekkøy K; David AS; Opjordsmoen S
    Compr Psychiatry; 2007; 48(6):583-91. PubMed ID: 17954145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-perceived cognitive functioning does not correlate with objective measures of cognition in schizophrenia.
    Johnson I; Tabbane K; Dellagi L; Kebir O
    Compr Psychiatry; 2011; 52(6):688-92. PubMed ID: 21296346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficit of executive functions in schizophrenia: relationship to neurological soft signs and psychopathology.
    Bersani G; Clemente R; Gherardelli S; Pancheri P
    Psychopathology; 2004; 37(3):118-23. PubMed ID: 15153743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between psychopathological variables and insight in psychosis risk syndrome and first-episode and multiepisode schizophrenia.
    Comparelli A; Savoja V; De Carolis A; Di Pietro S; Kotzalidis GD; Corigliano V; Falcone I; Tatarelli R; Ferracuti S; Girardi P
    J Nerv Ment Dis; 2013 Mar; 201(3):229-33. PubMed ID: 23407202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.